Full Text
PNL12 COST UTILITY ANALYSIS OF INTERFERON BETA-1A (AVONEX) IN PRE-CLINICALLY DEFINITE MULTIPLE SCLEROSIS (CDMS)

Abstract

Authors

M Iskedjian J Walker T Gray C Vicente T Einarson A Gehshan

Back to Volume 7, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×